1.
Oncol. clín
; 9(4): 1127-1135, nov. 2004. tab
Article
in Spanish
| LILACS
| ID: lil-400909
Subject(s)
Humans , Male , Prostatic Neoplasms , Antineoplastic Agents, Hormonal , Antineoplastic Agents/therapeutic use , Calcitriol , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Diphosphonates , Drug Resistance, Neoplasm , Estramustine , Granulocyte-Macrophage Colony-Stimulating Factor , Metalloproteins/antagonists & inhibitors , Mitoxantrone , Paclitaxel , Prostatic Neoplasms , Radiopharmaceuticals , Suramin , Survival Rate , Thalidomide , Treatment Outcome , Vinblastine , Vinca Alkaloids
2.
Oncol. clín
; 9(4): 1127-1135, nov. 2004. tab
Article
in Spanish
| BINACIS
| ID: bin-2371